PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
11.54
Positive P/E while CRN.AX shows losses. John Neff would investigate competitive advantages.
1.29
Similar P/S to CRN.AX's 1.51. David Dodd would investigate if similar multiples reflect similar business quality.
0.86
P/B 1.1-1.25x CRN.AX's 0.74. Bill Ackman would demand evidence of superior asset utilization.
25.82
P/FCF 50-75% of CRN.AX's 50.98. Bruce Berkowitz would examine if capital allocation explains the gap.
17.79
P/OCF 1.25-1.5x CRN.AX's 12.69. Martin Whitman would scrutinize if premium reflects better business model.
0.86
Fair value ratio 1.1-1.25x CRN.AX's 0.74. Bill Ackman would demand evidence of superior economics.
2.17%
Positive earnings while CRN.AX shows losses. John Neff would investigate earnings advantage.
3.87%
FCF yield exceeding 1.5x CRN.AX's 1.96%. David Dodd would verify if cash flow quality justifies this premium.